Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Mar 27, 2007

CytoGenix and USAMRIID Forge Biodefense Vaccines Partnership

  • CytoGenix entered into a CRADA with the United States Army Medical Research Institute of Infectious Diseases (USAMRIID) to develop and test synDNA™ vaccines for the prevention of disease caused by the Ebola virus and several strains of equine encephalitis viruses.

    “These disease targets are listed as Category A & B bioterrorism agents/diseases by the Centers for Disease Control,” points out Malcolm Skolnick, CEO.

    “Data collected under this CRADA will help to demonstrate the validity of use of synDNA™ vaccines in rapid response platforms, including the protection of our nation’s military personnel, health providers and other first responders, as well as the general population against a spectrum of existing and emerging terroristic and other infectious diseases.”



Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »